Medicenna Therapeutics Corp (MDNAF)
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
Issue of Equity
Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
i-80 Gold Announces Termination of Gold Offtake Agreement
FactSet Expands Model Context Protocol Suite to Portfolio Analytics
Allspring Closed-End Funds Declare Monthly Distributions
High Roller Technologies Awarded Guaranteed Introducing Broker License from National Futures Association to Enter Prediction Markets Space
BlockchAIn Digital Infrastructure, Inc. Completes Corporate Name Change to AIB Data Centers Inc.
CDT Highlights Sarborgs Application of Quantum Computing to Solid-Form Development
LIXTE Joins Russell Microcap Index